These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18023823)

  • 1. Exploring vascular dysfunction caused by tirapazamine.
    Huxham LA; Kyle AH; Baker JH; McNicol KL; Minchinton AI
    Microvasc Res; 2008 Mar; 75(2):247-55. PubMed ID: 18023823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts.
    Huxham LA; Kyle AH; Baker JH; McNicol KL; Minchinton AI
    Radiother Oncol; 2006 Feb; 78(2):138-45. PubMed ID: 16455148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging.
    Bains LJ; Baker JH; Kyle AH; Minchinton AI; Reinsberg SA
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):957-65. PubMed ID: 19480975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.
    Tozer GM; Prise VE; Wilson J; Cemazar M; Shan S; Dewhirst MW; Barber PR; Vojnovic B; Chaplin DJ
    Cancer Res; 2001 Sep; 61(17):6413-22. PubMed ID: 11522635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent.
    Henderson BW; Sitnik-Busch TM; Vaughan LA
    Photochem Photobiol; 1999 Jul; 70(1):64-71. PubMed ID: 10420844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxin.
    Baker JH; Kyle AH; Bartels KL; Methot SP; Flanagan EJ; Balbirnie A; Cran JD; Minchinton AI
    PLoS One; 2013; 8(10):e76832. PubMed ID: 24204680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy.
    Griffin RJ; Williams BW; Park HJ; Song CW
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1516-22. PubMed ID: 15817358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologic and cytotoxic effects of tirapazamine in tumor-bearing mice.
    Durand RE; Olive PL
    Radiat Oncol Investig; 1997; 5(5):213-9. PubMed ID: 9372543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues.
    Tozer GM; Prise VE; Wilson J; Locke RJ; Vojnovic B; Stratford MR; Dennis MF; Chaplin DJ
    Cancer Res; 1999 Apr; 59(7):1626-34. PubMed ID: 10197639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia.
    Siim BG; Menke DR; Dorie MJ; Brown JM
    Cancer Res; 1997 Jul; 57(14):2922-8. PubMed ID: 9230202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbogen breathing after irradiation enhances the effectiveness of tirapazamine in SiHa tumors but not SCCVII tumors in mice.
    Minchinton AI; Tonn DA; Sutherland DP; Kyle AH
    Radiat Res; 2002 Jul; 158(1):94-100. PubMed ID: 12071808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic cell cytotoxin tirapazamine induces acute changes in tumor energy metabolism and pH: a 31P magnetic resonance spectroscopy study.
    Aboagye EO; Dillehay LE; Bhujwalla ZM; Lee DJ
    Radiat Oncol Investig; 1998; 6(6):249-54. PubMed ID: 9885940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen dependence and extravascular transport of hypoxia-activated prodrugs: comparison of the dinitrobenzamide mustard PR-104A and tirapazamine.
    Hicks KO; Myint H; Patterson AV; Pruijn FB; Siim BG; Patel K; Wilson WR
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):560-71. PubMed ID: 17869669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the comet assay to identify cells sensitive to tirapazamine in multicell spheroids and tumors in mice.
    Olive PL; Vikse CM; Banath JP
    Cancer Res; 1996 Oct; 56(19):4460-3. PubMed ID: 8813141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay.
    Shibata T; Shibamoto Y; Sasai K; Oya N; Murata R; Takagi T; Hiraoka M; Takahashi M; Abe M
    Br J Cancer Suppl; 1996 Jul; 27():S61-4. PubMed ID: 8763848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia.
    Aboagye EO; Maxwell RJ; Kelson AB; Tracy M; Lewis AD; Graham MA; Horsman MR; Griffiths JR; Workman P
    Cancer Res; 1997 Aug; 57(15):3314-8. PubMed ID: 9242466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
    Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM
    Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation.
    Shibata T; Shibamoto Y; Sasai K; Oya N; Murata R; Takagi T; Hiraoka M; Abe M
    Jpn J Cancer Res; 1996 Jan; 87(1):98-104. PubMed ID: 8609056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
    Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
    Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma.
    Sun JR; Brown JM
    Cancer Res; 1989 Oct; 49(20):5664-70. PubMed ID: 2790784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.